icon-folder.gif   Conference Reports for NATAP  
 
  11th International Congress
on Drug Therapy in HIV Infection
11-15 November 2012 Glasgow, UK
Back grey_arrow_rt.gif
 
 
 
Enabling clinical development of an HIV attachment inhibitor through innovative pharmaceutical development: novel extended-release delivery of a prodrug
 
 
  Reported by Jules Levin
11th International Congress on Drug Therapy in HIV Infection
Glasgow 2012 Nov 11-14
 
Jonathan Brown,1 Mike Tobyn,1 Sarah Brown,1 Timothy Connolly,2 Andrew Dennis,1 George J Hanna,3 Helen Hughes,1 John Kadow,2 Nicholas Meanwell,2 Tao Wang,2 Kap-Sun Yeung,2 Li Zhu,4 Peter Timmins,1 1Bristol-Myers Squibb, Research and Development, Moreton, UK; 2Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA; 3Bristol-Myers Squibb, Research and Development, Princeton, NJ, USA, 4Bristol-Myers Squibb, Research and Development, Hopewell, NJ, USA

Glasgow1.gif

Glasgow2.gif

Glasgow3.gif

Glasgow4.gif

Glasgow5.gif

Glasgow6.gif

Glasgow7.gif

Glasgow8.gif

Glasgow9.gif

Glasgow10.gif

Glasgow11.gif